Loading…

Design, expression and characterization of recombinant hybrid peptide Attacin-Thanatin in Escherichia coli

Antimicrobial peptides will be attractive and potential candidates as peptide drugs because of their efficient action against microbes and low toxicity to mammal cells. To improve their antibacterial activity, some modifications needs to be made. In this research, the hybrid peptide gene Attacin-Tha...

Full description

Saved in:
Bibliographic Details
Published in:Molecular biology reports 2010-10, Vol.37 (7), p.3495-3501
Main Authors: Wang, Li Na, Yu, Bing, Han, Guo Quan, He, Jun, Chen, Dai Wen
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c402t-a2b114cb2e4709ae73f26c2fa680a06f4508ca2f1fdaeb4cfb33950a87ffa8a53
cites cdi_FETCH-LOGICAL-c402t-a2b114cb2e4709ae73f26c2fa680a06f4508ca2f1fdaeb4cfb33950a87ffa8a53
container_end_page 3501
container_issue 7
container_start_page 3495
container_title Molecular biology reports
container_volume 37
creator Wang, Li Na
Yu, Bing
Han, Guo Quan
He, Jun
Chen, Dai Wen
description Antimicrobial peptides will be attractive and potential candidates as peptide drugs because of their efficient action against microbes and low toxicity to mammal cells. To improve their antibacterial activity, some modifications needs to be made. In this research, the hybrid peptide gene Attacin-Thanatin with 642 bp in length with preferred codons of E. coli was generated using the technology of Gene splicing by overlap extension. The gene was inserted in-frame into E. coli expression plasmid pET-32a (+) and induced to express in E. coli Rosetta . The recombinant protein was partial purified and its biological activity was determined. Analysis of the E. coli Rosetta induced with IPTG revealed that the molecular weight of fusion protein was approximately 41.8 kDa, which perfectly matched the mass calculated from the amino acid sequence. Biological activity detection showed that this peptide effectively inhibited the growth of the test bacteria including E. coli DH5α, E. coli BL21 (DE3), Salmonella choleraesuis and Staphylococcus aureus . Among these bacteria, the Gram-negative E. coli was the most sensitive. Furthermore, there was minor hemolysis activity for porcine red blood cells. So, the results indicated that the hybrid peptide Attacin-Thanatin could be served as a promising candidate for the chemical antibiotics.
doi_str_mv 10.1007/s11033-009-9942-3
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_807279883</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2144876221</sourcerecordid><originalsourceid>FETCH-LOGICAL-c402t-a2b114cb2e4709ae73f26c2fa680a06f4508ca2f1fdaeb4cfb33950a87ffa8a53</originalsourceid><addsrcrecordid>eNp1kU1rHDEMhk1pabZpf0AvxfTSS53KX2vPMaRpGwj0kp6NxmNnvOx6pvYsJPn18bILgUJBIJAevRJ6CfnI4YIDmG-Vc5CSAXSs65Rg8hVZcW0kU52xr8kKJHCmrOZn5F2tGwBQ3Oi35Ix33dooLVZk8z3UdJ-_0vAwl1BrmjLFPFA_YkG_hJKecDkUp0hL8NOuTxnzQsfHvqSBzmFe0hDo5bKgT5ndjZgbn2mL6-rHNu_HhNRP2_SevIm4reHDKZ-TPz-u765-sdvfP2-uLm-ZVyAWhqLnXPleBGWgw2BkFGsvIq4tIKyj0mA9isjjgKFXPvZSdhrQmhjRopbn5MtRdy7T332oi9ul6sN2izlM--osGGE6a2UjP_9DbqZ9ye04Z7RQbaHmDeJHyJep1hKim0vaYXl0HNzBBne0wTUb3MEGdxD-dBLe97swvEyc_t4AcQRqa-X7UF42_1_1GSOAlCM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>752468051</pqid></control><display><type>article</type><title>Design, expression and characterization of recombinant hybrid peptide Attacin-Thanatin in Escherichia coli</title><source>Springer Link</source><creator>Wang, Li Na ; Yu, Bing ; Han, Guo Quan ; He, Jun ; Chen, Dai Wen</creator><creatorcontrib>Wang, Li Na ; Yu, Bing ; Han, Guo Quan ; He, Jun ; Chen, Dai Wen</creatorcontrib><description>Antimicrobial peptides will be attractive and potential candidates as peptide drugs because of their efficient action against microbes and low toxicity to mammal cells. To improve their antibacterial activity, some modifications needs to be made. In this research, the hybrid peptide gene Attacin-Thanatin with 642 bp in length with preferred codons of E. coli was generated using the technology of Gene splicing by overlap extension. The gene was inserted in-frame into E. coli expression plasmid pET-32a (+) and induced to express in E. coli Rosetta . The recombinant protein was partial purified and its biological activity was determined. Analysis of the E. coli Rosetta induced with IPTG revealed that the molecular weight of fusion protein was approximately 41.8 kDa, which perfectly matched the mass calculated from the amino acid sequence. Biological activity detection showed that this peptide effectively inhibited the growth of the test bacteria including E. coli DH5α, E. coli BL21 (DE3), Salmonella choleraesuis and Staphylococcus aureus . Among these bacteria, the Gram-negative E. coli was the most sensitive. Furthermore, there was minor hemolysis activity for porcine red blood cells. So, the results indicated that the hybrid peptide Attacin-Thanatin could be served as a promising candidate for the chemical antibiotics.</description><identifier>ISSN: 0301-4851</identifier><identifier>EISSN: 1573-4978</identifier><identifier>DOI: 10.1007/s11033-009-9942-3</identifier><identifier>PMID: 19967452</identifier><language>eng</language><publisher>Dordrecht: Springer Netherlands</publisher><subject>Animal Anatomy ; Animal Biochemistry ; Anti-Bacterial Agents - pharmacology ; Antimicrobial agents ; Antimicrobial Cationic Peptides - genetics ; Antimicrobial Cationic Peptides - isolation &amp; purification ; Antimicrobial Cationic Peptides - metabolism ; Antimicrobial Cationic Peptides - pharmacology ; Biomedical and Life Sciences ; Cellular biology ; E coli ; Electrophoresis, Polyacrylamide Gel ; Escherichia coli ; Escherichia coli - drug effects ; Escherichia coli - metabolism ; Gene expression ; Histology ; Life Sciences ; Microbial Sensitivity Tests ; Molecular biology ; Morphology ; Peptides ; Plasmids - genetics ; Protein Engineering - methods ; Proteins ; Recombinant Fusion Proteins - genetics ; Recombinant Fusion Proteins - isolation &amp; purification ; Recombinant Fusion Proteins - metabolism ; Recombinant Fusion Proteins - pharmacology ; Salmonella choleraesuis ; Staphylococcus aureus</subject><ispartof>Molecular biology reports, 2010-10, Vol.37 (7), p.3495-3501</ispartof><rights>Springer Science+Business Media B.V. 2009</rights><rights>Springer Science+Business Media B.V. 2010</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c402t-a2b114cb2e4709ae73f26c2fa680a06f4508ca2f1fdaeb4cfb33950a87ffa8a53</citedby><cites>FETCH-LOGICAL-c402t-a2b114cb2e4709ae73f26c2fa680a06f4508ca2f1fdaeb4cfb33950a87ffa8a53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19967452$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wang, Li Na</creatorcontrib><creatorcontrib>Yu, Bing</creatorcontrib><creatorcontrib>Han, Guo Quan</creatorcontrib><creatorcontrib>He, Jun</creatorcontrib><creatorcontrib>Chen, Dai Wen</creatorcontrib><title>Design, expression and characterization of recombinant hybrid peptide Attacin-Thanatin in Escherichia coli</title><title>Molecular biology reports</title><addtitle>Mol Biol Rep</addtitle><addtitle>Mol Biol Rep</addtitle><description>Antimicrobial peptides will be attractive and potential candidates as peptide drugs because of their efficient action against microbes and low toxicity to mammal cells. To improve their antibacterial activity, some modifications needs to be made. In this research, the hybrid peptide gene Attacin-Thanatin with 642 bp in length with preferred codons of E. coli was generated using the technology of Gene splicing by overlap extension. The gene was inserted in-frame into E. coli expression plasmid pET-32a (+) and induced to express in E. coli Rosetta . The recombinant protein was partial purified and its biological activity was determined. Analysis of the E. coli Rosetta induced with IPTG revealed that the molecular weight of fusion protein was approximately 41.8 kDa, which perfectly matched the mass calculated from the amino acid sequence. Biological activity detection showed that this peptide effectively inhibited the growth of the test bacteria including E. coli DH5α, E. coli BL21 (DE3), Salmonella choleraesuis and Staphylococcus aureus . Among these bacteria, the Gram-negative E. coli was the most sensitive. Furthermore, there was minor hemolysis activity for porcine red blood cells. So, the results indicated that the hybrid peptide Attacin-Thanatin could be served as a promising candidate for the chemical antibiotics.</description><subject>Animal Anatomy</subject><subject>Animal Biochemistry</subject><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Antimicrobial agents</subject><subject>Antimicrobial Cationic Peptides - genetics</subject><subject>Antimicrobial Cationic Peptides - isolation &amp; purification</subject><subject>Antimicrobial Cationic Peptides - metabolism</subject><subject>Antimicrobial Cationic Peptides - pharmacology</subject><subject>Biomedical and Life Sciences</subject><subject>Cellular biology</subject><subject>E coli</subject><subject>Electrophoresis, Polyacrylamide Gel</subject><subject>Escherichia coli</subject><subject>Escherichia coli - drug effects</subject><subject>Escherichia coli - metabolism</subject><subject>Gene expression</subject><subject>Histology</subject><subject>Life Sciences</subject><subject>Microbial Sensitivity Tests</subject><subject>Molecular biology</subject><subject>Morphology</subject><subject>Peptides</subject><subject>Plasmids - genetics</subject><subject>Protein Engineering - methods</subject><subject>Proteins</subject><subject>Recombinant Fusion Proteins - genetics</subject><subject>Recombinant Fusion Proteins - isolation &amp; purification</subject><subject>Recombinant Fusion Proteins - metabolism</subject><subject>Recombinant Fusion Proteins - pharmacology</subject><subject>Salmonella choleraesuis</subject><subject>Staphylococcus aureus</subject><issn>0301-4851</issn><issn>1573-4978</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><recordid>eNp1kU1rHDEMhk1pabZpf0AvxfTSS53KX2vPMaRpGwj0kp6NxmNnvOx6pvYsJPn18bILgUJBIJAevRJ6CfnI4YIDmG-Vc5CSAXSs65Rg8hVZcW0kU52xr8kKJHCmrOZn5F2tGwBQ3Oi35Ix33dooLVZk8z3UdJ-_0vAwl1BrmjLFPFA_YkG_hJKecDkUp0hL8NOuTxnzQsfHvqSBzmFe0hDo5bKgT5ndjZgbn2mL6-rHNu_HhNRP2_SevIm4reHDKZ-TPz-u765-sdvfP2-uLm-ZVyAWhqLnXPleBGWgw2BkFGsvIq4tIKyj0mA9isjjgKFXPvZSdhrQmhjRopbn5MtRdy7T332oi9ul6sN2izlM--osGGE6a2UjP_9DbqZ9ye04Z7RQbaHmDeJHyJep1hKim0vaYXl0HNzBBne0wTUb3MEGdxD-dBLe97swvEyc_t4AcQRqa-X7UF42_1_1GSOAlCM</recordid><startdate>20101001</startdate><enddate>20101001</enddate><creator>Wang, Li Na</creator><creator>Yu, Bing</creator><creator>Han, Guo Quan</creator><creator>He, Jun</creator><creator>Chen, Dai Wen</creator><general>Springer Netherlands</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7TM</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>RC3</scope><scope>7QL</scope><scope>C1K</scope><scope>F1W</scope><scope>H95</scope><scope>H97</scope><scope>L.G</scope></search><sort><creationdate>20101001</creationdate><title>Design, expression and characterization of recombinant hybrid peptide Attacin-Thanatin in Escherichia coli</title><author>Wang, Li Na ; Yu, Bing ; Han, Guo Quan ; He, Jun ; Chen, Dai Wen</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c402t-a2b114cb2e4709ae73f26c2fa680a06f4508ca2f1fdaeb4cfb33950a87ffa8a53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Animal Anatomy</topic><topic>Animal Biochemistry</topic><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Antimicrobial agents</topic><topic>Antimicrobial Cationic Peptides - genetics</topic><topic>Antimicrobial Cationic Peptides - isolation &amp; purification</topic><topic>Antimicrobial Cationic Peptides - metabolism</topic><topic>Antimicrobial Cationic Peptides - pharmacology</topic><topic>Biomedical and Life Sciences</topic><topic>Cellular biology</topic><topic>E coli</topic><topic>Electrophoresis, Polyacrylamide Gel</topic><topic>Escherichia coli</topic><topic>Escherichia coli - drug effects</topic><topic>Escherichia coli - metabolism</topic><topic>Gene expression</topic><topic>Histology</topic><topic>Life Sciences</topic><topic>Microbial Sensitivity Tests</topic><topic>Molecular biology</topic><topic>Morphology</topic><topic>Peptides</topic><topic>Plasmids - genetics</topic><topic>Protein Engineering - methods</topic><topic>Proteins</topic><topic>Recombinant Fusion Proteins - genetics</topic><topic>Recombinant Fusion Proteins - isolation &amp; purification</topic><topic>Recombinant Fusion Proteins - metabolism</topic><topic>Recombinant Fusion Proteins - pharmacology</topic><topic>Salmonella choleraesuis</topic><topic>Staphylococcus aureus</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wang, Li Na</creatorcontrib><creatorcontrib>Yu, Bing</creatorcontrib><creatorcontrib>Han, Guo Quan</creatorcontrib><creatorcontrib>He, Jun</creatorcontrib><creatorcontrib>Chen, Dai Wen</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Science Database (ProQuest)</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>Genetics Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ASFA: Aquatic Sciences and Fisheries Abstracts</collection><collection>Aquatic Science &amp; Fisheries Abstracts (ASFA) 1: Biological Sciences &amp; Living Resources</collection><collection>Aquatic Science &amp; Fisheries Abstracts (ASFA) 3: Aquatic Pollution &amp; Environmental Quality</collection><collection>Aquatic Science &amp; Fisheries Abstracts (ASFA) Professional</collection><jtitle>Molecular biology reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wang, Li Na</au><au>Yu, Bing</au><au>Han, Guo Quan</au><au>He, Jun</au><au>Chen, Dai Wen</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Design, expression and characterization of recombinant hybrid peptide Attacin-Thanatin in Escherichia coli</atitle><jtitle>Molecular biology reports</jtitle><stitle>Mol Biol Rep</stitle><addtitle>Mol Biol Rep</addtitle><date>2010-10-01</date><risdate>2010</risdate><volume>37</volume><issue>7</issue><spage>3495</spage><epage>3501</epage><pages>3495-3501</pages><issn>0301-4851</issn><eissn>1573-4978</eissn><abstract>Antimicrobial peptides will be attractive and potential candidates as peptide drugs because of their efficient action against microbes and low toxicity to mammal cells. To improve their antibacterial activity, some modifications needs to be made. In this research, the hybrid peptide gene Attacin-Thanatin with 642 bp in length with preferred codons of E. coli was generated using the technology of Gene splicing by overlap extension. The gene was inserted in-frame into E. coli expression plasmid pET-32a (+) and induced to express in E. coli Rosetta . The recombinant protein was partial purified and its biological activity was determined. Analysis of the E. coli Rosetta induced with IPTG revealed that the molecular weight of fusion protein was approximately 41.8 kDa, which perfectly matched the mass calculated from the amino acid sequence. Biological activity detection showed that this peptide effectively inhibited the growth of the test bacteria including E. coli DH5α, E. coli BL21 (DE3), Salmonella choleraesuis and Staphylococcus aureus . Among these bacteria, the Gram-negative E. coli was the most sensitive. Furthermore, there was minor hemolysis activity for porcine red blood cells. So, the results indicated that the hybrid peptide Attacin-Thanatin could be served as a promising candidate for the chemical antibiotics.</abstract><cop>Dordrecht</cop><pub>Springer Netherlands</pub><pmid>19967452</pmid><doi>10.1007/s11033-009-9942-3</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0301-4851
ispartof Molecular biology reports, 2010-10, Vol.37 (7), p.3495-3501
issn 0301-4851
1573-4978
language eng
recordid cdi_proquest_miscellaneous_807279883
source Springer Link
subjects Animal Anatomy
Animal Biochemistry
Anti-Bacterial Agents - pharmacology
Antimicrobial agents
Antimicrobial Cationic Peptides - genetics
Antimicrobial Cationic Peptides - isolation & purification
Antimicrobial Cationic Peptides - metabolism
Antimicrobial Cationic Peptides - pharmacology
Biomedical and Life Sciences
Cellular biology
E coli
Electrophoresis, Polyacrylamide Gel
Escherichia coli
Escherichia coli - drug effects
Escherichia coli - metabolism
Gene expression
Histology
Life Sciences
Microbial Sensitivity Tests
Molecular biology
Morphology
Peptides
Plasmids - genetics
Protein Engineering - methods
Proteins
Recombinant Fusion Proteins - genetics
Recombinant Fusion Proteins - isolation & purification
Recombinant Fusion Proteins - metabolism
Recombinant Fusion Proteins - pharmacology
Salmonella choleraesuis
Staphylococcus aureus
title Design, expression and characterization of recombinant hybrid peptide Attacin-Thanatin in Escherichia coli
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T07%3A39%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Design,%20expression%20and%20characterization%20of%20recombinant%20hybrid%20peptide%20Attacin-Thanatin%20in%20Escherichia%20coli&rft.jtitle=Molecular%20biology%20reports&rft.au=Wang,%20Li%20Na&rft.date=2010-10-01&rft.volume=37&rft.issue=7&rft.spage=3495&rft.epage=3501&rft.pages=3495-3501&rft.issn=0301-4851&rft.eissn=1573-4978&rft_id=info:doi/10.1007/s11033-009-9942-3&rft_dat=%3Cproquest_cross%3E2144876221%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c402t-a2b114cb2e4709ae73f26c2fa680a06f4508ca2f1fdaeb4cfb33950a87ffa8a53%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=752468051&rft_id=info:pmid/19967452&rfr_iscdi=true